Medivir AB (publ.)
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Ethical rules and guidelines
- Environmental impact
- Safe and developmental work environment
Environmental Achievements
- Carried out a first climate calculation to gain control over the emissions associated with the company's business trips, energy useage and consumption.
Social Achievements
- Strives to create a working environment that promotes health and well-being.
- Implemented a management system for the company's sustainability work and reporting.
Governance Achievements
- Implemented a management system for the company's sustainability work and reporting.
- Adopted a new Articles of Association
Climate Goals & Targets
Medium-term Goals:
- Set long-term, measurable sustainability goals for Medivir's four essential areas.
Short-term Goals:
- Establish a Code of Conduct for the company's suppliers.
Environmental Challenges
- High risk and capital-intensive pharmaceutical development process.
- Competition from other companies developing similar pharmaceuticals.
- Uncertainty in the global environment (e.g., geopolitical conflicts, inflation).
Mitigation Strategies
- Continuous risk assessment and management.
- Partnerships to accelerate development and reduce financial risk.
- Active environmental and occupational health and safety program.
Supply Chain Management
Responsible Procurement
- Environmental and sustainability regulations are important factors to consider before entering into an agreement with subcontractors.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: IFRS
Third-party Assurance: Grant Thornton Sweden AB
UN Sustainable Development Goals
- Goal 3
- Goal 8
- Goal 9
- Goal 12
Medivir's sustainability work shall contribute to the UN's 17 global goals for sustainable development.